UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF JULY 2021


COMMISSION FILE NUMBER 001-38976

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  Form 40-F 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)

Yes  No 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)

Yes  No 

This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

nthony

GENMAB A/S

BY:

/s/ Anthony Pagano

Name: Anthony Pagano

Title: Executive Vice President & Chief Financial Officer

DATE: July 1, 2021


EXHIBIT INDEX

O

Exhibit

Description of Exhibit

99.1

Company Announcement Dated July 1, 2021: Completion of share buy-back program

99.1(a)

Appendix: Transactions June 28-30, 2021


Exhibit 99.1

Graphic

Completion of share buy-back program

Company Announcement

COPENHAGEN, Denmark; July 01, 2021 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on June 30, 2021.

On February 23, 2021 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program.

The share buy-back program was expected to be completed no later than June 30, 2021 and comprised up to 200,000 shares.

The following transactions were executed under the program from June 28, 2021, to June 30, 2021:

 

No. of shares

Average price (DKK)

Total value (DKK)

Accumulated through last announcement

193,400

 

429,072,364

June 28, 2021

3,000

2,609.07

7,827,210

June 29, 2021

2,000

2,601.09

5,202,180

June 30, 2021

1,600

2,580.80

4,129,280

Total

6,600

17,158,670

Accumulated under the program

200,000

 

446,231,034

Details of each transaction are included as an appendix to this announcement.

Genmab’s accumulated share buy-back from 24 February 2021 to 30 June, 2021 amounts to 200,000 shares at a total cost of DKK 446.23 million. The announced share buy-back program has thus been completed.

Following these transactions, Genmab holds 299,206 shares as treasury shares, corresponding to 0.46% of the total share capital and voting rights.

The share buy-back program was undertaken in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Further details on the terms of the share buy-back program can be found in our company announcement no. 11 dated February 23, 2021.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab’s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 56

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 1/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Graphic

Completion of share buy-back program

enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please

visit Genmab.com.


Contact:
Marisol Peron, Senior Vice President, Global Investor Relations & Communications

T: +1 609 524 0065; E: mmp@genmab.com

For Investor Relations:

Andrew Carlsen, Vice President, Head of Investor Relations

T: +45 3377 9558; E: acn@genmab.com


This Company Announcement contains forward looking statements. The words “believe”, “expect”, “anticipate”, “intend” and “plan” and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab’s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab’s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law.


Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; DuoBody in combination with the DuoBody logo®; HexaBody®; HexaBody in combination with the HexaBody logo®; DuoHexaBody® and HexElect®.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 56

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 2/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

Volume

Price

Venue

Time CET

1

2602

XCSE

20210630 9:17:10.490000

18

2602

XCSE

20210630 9:19:38.541000

10

2609

XCSE

20210630 9:26:33.484000

12

2609

XCSE

20210630 9:26:33.484000

18

2602

XCSE

20210630 9:35:00.373000

6

2600

XCSE

20210630 9:43:57.551000

12

2600

XCSE

20210630 9:43:57.551000

18

2596

XCSE

20210630 9:52:54.474000

35

2595

XCSE

20210630 9:59:53.189436

15

2595

XCSE

20210630 9:59:53.189471

18

2594

XCSE

20210630 10:01:57.472000

18

2593

XCSE

20210630 10:02:53.476000

40

2593

XCSE

20210630 10:03:47.719000

20

2584

XCSE

20210630 10:12:20.127000

18

2581

XCSE

20210630 10:22:51.496000

19

2586

XCSE

20210630 10:24:27.726000

27

2589

XCSE

20210630 10:37:40.429000

18

2593

XCSE

20210630 10:49:51.848000

14

2587

XCSE

20210630 10:59:55.118000

4

2587

XCSE

20210630 11:00:00.650000

18

2588

XCSE

20210630 11:01:34.912000

1

2585

XCSE

20210630 11:13:41.549000

17

2585

XCSE

20210630 11:13:41.549000

4

2584

XCSE

20210630 11:24:36.143000

14

2584

XCSE

20210630 11:24:36.143000

15

2584

XCSE

20210630 11:24:36.143908

6

2584

XCSE

20210630 11:24:36.143953

29

2584

XCSE

20210630 11:24:36.143985

21

2586

XCSE

20210630 11:31:30.650000

11

2582

XCSE

20210630 11:43:46.974000

7

2582

XCSE

20210630 11:43:47.000000

18

2585

XCSE

20210630 11:54:21.326000

22

2583

XCSE

20210630 12:06:21.176000

18

2582

XCSE

20210630 12:21:41.322000

18

2581

XCSE

20210630 12:26:56.552000

18

2579

XCSE

20210630 12:40:53.425000

18

2578

XCSE

20210630 12:58:36.342000

18

2578

XCSE

20210630 12:58:36.342000

18

2580

XCSE

20210630 13:12:39.140000

1


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

7

2586

XCSE

20210630 13:32:14.484000

11

2586

XCSE

20210630 13:32:14.484000

18

2586

XCSE

20210630 13:32:14.484000

19

2586

XCSE

20210630 13:50:12.343000

18

2584

XCSE

20210630 14:12:16.975000

18

2584

XCSE

20210630 14:12:16.975000

20

2584

XCSE

20210630 14:12:16.975599

20

2584

XCSE

20210630 14:12:17.001071

15

2584

XCSE

20210630 14:12:17.001071

6

2584

XCSE

20210630 14:12:17.001117

17

2584

XCSE

20210630 14:12:17.002089

3

2584

XCSE

20210630 14:12:17.002117

19

2584

XCSE

20210630 14:12:17.002526

19

2587

XCSE

20210630 14:20:26.926000

18

2581

XCSE

20210630 14:36:51.784000

18

2581

XCSE

20210630 14:36:51.784000

4

2580

XCSE

20210630 14:36:57.525003

46

2580

XCSE

20210630 14:36:57.550525

19

2578

XCSE

20210630 14:56:15.636000

18

2577

XCSE

20210630 15:05:01.163000

6

2577

XCSE

20210630 15:08:16.423000

12

2577

XCSE

20210630 15:08:33.240000

15

2575

XCSE

20210630 15:15:07.602623

35

2575

XCSE

20210630 15:15:07.602664

18

2574

XCSE

20210630 15:16:57.501000

17

2575

XCSE

20210630 15:21:50.112000

15

2575

XCSE

20210630 15:21:50.113000

18

2575

XCSE

20210630 15:21:50.113000

10

2575

XCSE

20210630 15:21:50.113000

18

2575

XCSE

20210630 15:25:35.114000

3

2577

XCSE

20210630 15:28:28.726000

19

2577

XCSE

20210630 15:29:32.438000

15

2577

XCSE

20210630 15:29:32.438000

18

2574

XCSE

20210630 15:32:03.528000

24

2579

XCSE

20210630 15:37:51.198000

23

2579

XCSE

20210630 15:37:51.198000

1

2574

XCSE

20210630 15:46:09.214000

22

2574

XCSE

20210630 15:46:09.214000

12

2574

XCSE

20210630 15:46:09.214000

18

2574

XCSE

20210630 15:46:09.214000

2


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

18

2572

XCSE

20210630 15:51:39.173000

19

2567

XCSE

20210630 15:57:55.567000

18

2567

XCSE

20210630 15:57:55.567000

30

2568

XCSE

20210630 15:58:49.923639

11

2568

XCSE

20210630 15:58:49.923639

19

2568

XCSE

20210630 15:58:49.923639

10

2568

XCSE

20210630 15:58:59.543494

15

2571

XCSE

20210630 16:03:13.396000

3

2571

XCSE

20210630 16:03:13.396000

10

2568

XCSE

20210630 16:06:01.373071

10

2568

XCSE

20210630 16:06:01.423586

10

2568

XCSE

20210630 16:06:01.438568

18

2566

XCSE

20210630 16:07:25.585000

18

2566

XCSE

20210630 16:10:23.726000

6

2569

XCSE

20210630 16:17:23.590000

18

2569

XCSE

20210630 16:17:23.590000

73

2568

XCSE

20210630 16:18:29.150086

10

2568

XCSE

20210630 16:18:29.150086

18

2606

XCSE

20210629 9:02:47.145000

16

2609

XCSE

20210629 9:06:40.128000

13

2609

XCSE

20210629 9:06:40.128000

19

2615

XCSE

20210629 9:10:15.448000

4

2615

XCSE

20210629 9:10:15.870000

20

2615

XCSE

20210629 9:11:30.041000

18

2617

XCSE

20210629 9:15:38.846000

20

2611

XCSE

20210629 9:18:16.180000

19

2611

XCSE

20210629 9:21:16.116000

19

2609

XCSE

20210629 9:25:11.822000

18

2605

XCSE

20210629 9:28:27.205000

15

2610

XCSE

20210629 9:33:11.102000

4

2610

XCSE

20210629 9:33:11.102000

18

2607

XCSE

20210629 9:37:15.591000

19

2603

XCSE

20210629 9:41:47.391000

19

2604

XCSE

20210629 9:46:55.338000

21

2606

XCSE

20210629 9:53:34.882000

22

2605

XCSE

20210629 9:57:18.667000

18

2606

XCSE

20210629 10:01:46.949000

18

2602

XCSE

20210629 10:06:23.366000

11

2603

XCSE

20210629 10:10:46.202000

7

2603

XCSE

20210629 10:10:46.202000

3


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

8

2598

XCSE

20210629 10:17:13.251436

18

2598

XCSE

20210629 10:18:06.703000

42

2598

XCSE

20210629 10:18:06.703993

18

2594

XCSE

20210629 10:22:03.134000

1

2596

XCSE

20210629 10:32:30.094000

18

2596

XCSE

20210629 10:32:30.094000

25

2601

XCSE

20210629 10:36:40.494000

27

2599

XCSE

20210629 10:45:01.496000

11

2599

XCSE

20210629 10:55:42.188000

14

2599

XCSE

20210629 10:55:42.188000

3

2601

XCSE

20210629 11:05:33.942000

27

2601

XCSE

20210629 11:05:33.942000

18

2600

XCSE

20210629 11:10:48.794000

18

2599

XCSE

20210629 11:19:25.097000

30

2599

XCSE

20210629 11:30:36.506000

21

2604

XCSE

20210629 11:53:38.428000

6

2604

XCSE

20210629 11:53:38.429000

15

2604

XCSE

20210629 11:53:38.429000

5

2604

XCSE

20210629 11:53:38.429000

18

2606

XCSE

20210629 12:02:06.382000

8

2608

XCSE

20210629 12:13:38.870000

18

2608

XCSE

20210629 12:13:38.870000

11

2610

XCSE

20210629 12:23:08.411000

8

2610

XCSE

20210629 12:24:59.595000

7

2611

XCSE

20210629 12:38:40.918000

14

2611

XCSE

20210629 12:38:40.928000

34

2611

XCSE

20210629 12:49:39.983000

18

2610

XCSE

20210629 13:00:27.876000

18

2606

XCSE

20210629 13:13:49.870000

18

2605

XCSE

20210629 13:21:25.139000

19

2604

XCSE

20210629 13:35:40.033000

30

2606

XCSE

20210629 13:43:05.353000

19

2607

XCSE

20210629 13:52:50.537000

21

2605

XCSE

20210629 14:00:18.059000

18

2604

XCSE

20210629 14:11:07.268000

20

2613

XCSE

20210629 14:18:16.093000

2

2612

XCSE

20210629 14:28:09.543000

16

2612

XCSE

20210629 14:28:09.543000

1

2611

XCSE

20210629 14:33:43.427000

23

2610

XCSE

20210629 14:40:25.667000

4


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

8

2609

XCSE

20210629 14:57:06.923000

30

2609

XCSE

20210629 14:57:06.923000

20

2611

XCSE

20210629 15:04:37.252000

19

2611

XCSE

20210629 15:04:37.252000

18

2609

XCSE

20210629 15:12:18.423000

20

2609

XCSE

20210629 15:17:27.917000

2

2608

XCSE

20210629 15:17:42.115000

19

2608

XCSE

20210629 15:17:42.115000

8

2607

XCSE

20210629 15:19:38.857000

12

2607

XCSE

20210629 15:19:52.652000

18

2606

XCSE

20210629 15:22:58.475000

21

2606

XCSE

20210629 15:23:17.826000

2

2607

XCSE

20210629 15:26:02.759000

20

2607

XCSE

20210629 15:26:02.759000

19

2607

XCSE

20210629 15:26:02.759000

42

2594

XCSE

20210629 16:02:12.542068

90

2593

XCSE

20210629 16:03:35.851465

10

2593

XCSE

20210629 16:03:35.851465

100

2590

XCSE

20210629 16:16:52.550009

20

2591

XCSE

20210629 16:26:07.439464

80

2591

XCSE

20210629 16:26:07.439464

200

2595

XCSE

20210629 16:38:02.134607

20

2593

XCSE

20210629 16:47:21.944073

180

2593

XCSE

20210629 16:47:21.944073

22

2605

XCSE

20210628 9:00:00.962000

9

2605

XCSE

20210628 9:00:00.962000

20

2596

XCSE

20210628 9:02:00.078000

27

2602

XCSE

20210628 9:04:30.120000

38

2610

XCSE

20210628 9:09:20.594000

12

2610

XCSE

20210628 9:09:20.594000

19

2605

XCSE

20210628 9:11:59.877000

19

2603

XCSE

20210628 9:14:00.556000

22

2599

XCSE

20210628 9:15:28.949000

18

2601

XCSE

20210628 9:17:24.930000

18

2603

XCSE

20210628 9:19:29.436000

19

2604

XCSE

20210628 9:22:20.425000

5

2608

XCSE

20210628 9:24:52.004000

22

2608

XCSE

20210628 9:24:52.004000

20

2606

XCSE

20210628 9:27:08.859000

18

2604

XCSE

20210628 9:31:01.927000

5


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

11

2600

XCSE

20210628 9:33:07.536000

8

2600

XCSE

20210628 9:33:07.536000

19

2587

XCSE

20210628 9:35:59.010000

6

2587

XCSE

20210628 9:38:41.208000

16

2587

XCSE

20210628 9:38:41.208000

30

2590

XCSE

20210628 9:44:09.450000

19

2589

XCSE

20210628 9:46:50.668000

5

2589

XCSE

20210628 9:50:00.564000

15

2589

XCSE

20210628 9:50:00.564000

18

2588

XCSE

20210628 9:53:30.696000

19

2591

XCSE

20210628 9:56:31.626000

18

2596

XCSE

20210628 9:59:18.522000

19

2594

XCSE

20210628 10:02:52.630000

18

2596

XCSE

20210628 10:06:26.542000

18

2598

XCSE

20210628 10:09:44.993000

29

2595

XCSE

20210628 10:14:50.816000

18

2589

XCSE

20210628 10:20:03.551000

18

2590

XCSE

20210628 10:21:31.028000

19

2589

XCSE

20210628 10:25:18.430000

1

2589

XCSE

20210628 10:25:18.430000

18

2590

XCSE

20210628 10:29:35.929000

21

2594

XCSE

20210628 10:33:13.404000

19

2594

XCSE

20210628 10:37:31.466000

7

2595

XCSE

20210628 10:41:55.987000

11

2595

XCSE

20210628 10:41:55.988000

27

2598

XCSE

20210628 10:47:22.309000

19

2597

XCSE

20210628 10:52:51.893000

18

2596

XCSE

20210628 10:56:30.182000

18

2594

XCSE

20210628 11:00:06.134000

23

2593

XCSE

20210628 11:06:49.171000

2

2596

XCSE

20210628 11:15:24.310000

9

2596

XCSE

20210628 11:15:24.310000

7

2596

XCSE

20210628 11:15:24.310000

44

2601

XCSE

20210628 11:21:55.594000

24

2601

XCSE

20210628 11:30:28.434000

12

2601

XCSE

20210628 11:35:15.797000

3

2601

XCSE

20210628 11:35:20.796000

1

2601

XCSE

20210628 11:35:25.794000

10

2601

XCSE

20210628 11:35:40.535000

18

2601

XCSE

20210628 11:40:24.588000

6


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

18

2605

XCSE

20210628 11:46:20.568000

18

2598

XCSE

20210628 11:55:15.221000

3

2598

XCSE

20210628 11:55:15.221000

18

2596

XCSE

20210628 12:03:05.527000

19

2596

XCSE

20210628 12:07:46.102000

18

2595

XCSE

20210628 12:12:01.052000

18

2595

XCSE

20210628 12:18:00.582000

20

2603

XCSE

20210628 12:29:57.671000

15

2603

XCSE

20210628 12:29:57.671000

28

2607

XCSE

20210628 12:39:02.216000

26

2611

XCSE

20210628 12:55:24.773000

29

2611

XCSE

20210628 12:57:59.261000

24

2612

XCSE

20210628 13:06:45.393000

19

2609

XCSE

20210628 13:12:20.690000

19

2608

XCSE

20210628 13:20:47.501000

7

2607

XCSE

20210628 13:25:00.125000

12

2607

XCSE

20210628 13:25:00.125000

18

2606

XCSE

20210628 13:30:29.276000

21

2607

XCSE

20210628 13:40:57.219000

25

2607

XCSE

20210628 13:48:00.529000

19

2606

XCSE

20210628 13:53:19.595000

23

2607

XCSE

20210628 13:59:55.351000

26

2610

XCSE

20210628 14:03:00.053000

18

2610

XCSE

20210628 14:11:07.230000

12

2609

XCSE

20210628 14:17:50.594000

6

2609

XCSE

20210628 14:17:50.594000

18

2609

XCSE

20210628 14:21:38.699000

19

2606

XCSE

20210628 14:27:31.138000

19

2608

XCSE

20210628 14:39:41.882000

16

2608

XCSE

20210628 14:39:41.882000

25

2609

XCSE

20210628 14:46:02.053000

1

2608

XCSE

20210628 14:48:17.147000

18

2607

XCSE

20210628 14:51:32.343000

18

2604

XCSE

20210628 14:55:56.926000

19

2605

XCSE

20210628 15:01:21.684000

19

2605

XCSE

20210628 15:01:21.684000

20

2605

XCSE

20210628 15:04:41.617000

20

2607

XCSE

20210628 15:10:07.957000

18

2609

XCSE

20210628 15:15:44.892000

18

2609

XCSE

20210628 15:15:44.892000

7


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

4

2609

XCSE

20210628 15:21:57.018000

67

2609

XCSE

20210628 15:21:57.018000

65

2612

XCSE

20210628 15:28:11.214000

72

2612

XCSE

20210628 15:28:11.214000

32

2612

XCSE

20210628 15:28:11.214000

23

2622

XCSE

20210628 15:32:13.430000

1

2622

XCSE

20210628 15:32:13.430000

25

2622

XCSE

20210628 15:32:13.430000

26

2622

XCSE

20210628 15:32:13.430000

23

2622

XCSE

20210628 15:32:13.430000

13

2622

XCSE

20210628 15:32:13.430000

19

2618

XCSE

20210628 15:33:29.608000

16

2620

XCSE

20210628 15:35:00.045000

3

2620

XCSE

20210628 15:35:00.045000

16

2620

XCSE

20210628 15:35:00.045000

3

2620

XCSE

20210628 15:35:00.045000

21

2624

XCSE

20210628 15:37:03.189000

5

2624

XCSE

20210628 15:37:03.189000

36

2624

XCSE

20210628 15:37:03.189000

19

2623

XCSE

20210628 15:38:35.806000

17

2622

XCSE

20210628 15:38:43.189000

2

2622

XCSE

20210628 15:38:43.189000

18

2621

XCSE

20210628 15:40:03.602000

13

2628

XCSE

20210628 15:41:40.573000

9

2628

XCSE

20210628 15:41:40.573000

23

2628

XCSE

20210628 15:41:40.573000

18

2623

XCSE

20210628 15:42:54.801000

19

2622

XCSE

20210628 15:44:41.980000

20

2622

XCSE

20210628 15:44:41.980000

19

2619

XCSE

20210628 15:46:55.697000

29

2624

XCSE

20210628 15:49:27.498000

33

2624

XCSE

20210628 15:49:27.498000

19

2619

XCSE

20210628 15:51:13.760000

18

2617

XCSE

20210628 15:52:24.078000

32

2618

XCSE

20210628 15:54:33.946000

20

2616

XCSE

20210628 15:55:24.911000

19

2614

XCSE

20210628 15:56:33.444000

10

2613

XCSE

20210628 16:03:43.299000

30

2618

XCSE

20210628 16:07:31.233000

5

2618

XCSE

20210628 16:07:31.233000

8


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for June 28-30, 2021

Graphic

30

2618

XCSE

20210628 16:07:31.233000

12

2618

XCSE

20210628 16:07:36.954000

18

2618

XCSE

20210628 16:07:36.954000

20

2618

XCSE

20210628 16:07:36.954000

30

2618

XCSE

20210628 16:07:36.954000

8

2619

XCSE

20210628 16:09:34.081000

18

2619

XCSE

20210628 16:10:53.378000

18

2619

XCSE

20210628 16:10:53.378000

20

2619

XCSE

20210628 16:12:25.188000

36

2623

XCSE

20210628 16:16:21.604000

27

2623

XCSE

20210628 16:16:21.604000

24

2625

XCSE

20210628 16:20:40.183000

19

2625

XCSE

20210628 16:20:40.183000

19

2623

XCSE

20210628 16:26:34.287000

18

2623

XCSE

20210628 16:26:34.287000

18

2616

XCSE

20210628 16:28:48.007000

21

2615

XCSE

20210628 16:32:32.989000

18

2618

XCSE

20210628 16:34:03.090000

5

2618

XCSE

20210628 16:38:10.615334

5

2618

XCSE

20210628 16:38:10.615355

5

2618

XCSE

20210628 16:38:10.615364

5

2618

XCSE

20210628 16:38:10.615378

4

2618

XCSE

20210628 16:38:20.621000

6

2618

XCSE

20210628 16:38:20.621031

54

2618

XCSE

20210628 16:39:01.898719

10

2618

XCSE

20210628 16:39:01.898719

9